Andrea Rose, R.N

NPI: 1033544499
Total Payments
$239.28
2023 Payments
$97.74
Companies
2
Transactions
14

Payment Breakdown by Category

Food & Beverage$239.28 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $239.28 14 100.0%

Top Paying Companies

Company Total Records Latest Year
Supernus Pharmaceuticals, Inc. $216.48 13 $0 (2023)
Otsuka America Pharmaceutical, Inc. $22.80 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2023 $97.74 5 Supernus Pharmaceuticals, Inc. ($74.94)
2022 $141.54 9 Supernus Pharmaceuticals, Inc. ($141.54)

All Payment Transactions

14 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
05/07/2023 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $19.81 General
Category: PSYCHOLOGY
04/11/2023 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $18.61 General
Category: PSYCHOLOGY
03/22/2023 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $18.82 General
Category: PSYCHOLOGY
03/01/2023 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $22.80 General
Category: PSYCHIATRY
01/27/2023 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $17.70 General
Category: PSYCHOLOGY
11/08/2022 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $18.08 General
Category: PSYCHOLOGY
09/12/2022 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $18.43 General
Category: PSYCHOLOGY
08/12/2022 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $17.83 General
Category: PSYCHOLOGY
07/21/2022 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $10.97 General
Category: PSYCHOLOGY
07/07/2022 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $14.80 General
Category: PSYCHOLOGY
06/14/2022 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $15.50 General
Category: PSYCHOLOGY
04/07/2022 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $7.22 General
Category: PSYCHOLOGY
03/10/2022 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $19.87 General
Category: PSYCHOLOGY
02/17/2022 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $18.84 General
Category: PSYCHOLOGY

About Andrea Rose, R.N

Andrea Rose, R.N is a Addiction (Substance Use Disorder) healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/04/2013. The National Provider Identifier (NPI) number assigned to this provider is 1033544499.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Andrea Rose, R.N has received a total of $239.28 in payments from pharmaceutical and medical device companies, with $97.74 received in 2023. These payments were reported across 14 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($239.28).

Practice Information

  • Specialty Addiction (Substance Use Disorder)
  • Location Tulsa, OK
  • Active Since 09/04/2013
  • Last Updated 09/04/2013
  • Taxonomy Code 163WA0400X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1033544499

Products in Payments

  • QELBREE (Drug) $216.48
  • REXULTI (Drug) $22.80

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Addiction (Substance Use Disorder) Doctors in Tulsa